MedKoo Cat#: 532817 | Name: TG4-155
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TG4-155 is a brain penetrant EP2 antagonist (KB = 2.4 nM) that is over 1000-fold less effective at EP4 (KB = 11.4 µM) and a panel of other receptors and channels. It blocks the induced expression of inflammatory markers in microglial cells

Chemical Structure

TG4-155
TG4-155
CAS#1164462-05-8

Theoretical Analysis

MedKoo Cat#: 532817

Name: TG4-155

CAS#: 1164462-05-8

Chemical Formula: C23H26N2O4

Exact Mass: 394.1893

Molecular Weight: 394.47

Elemental Analysis: C, 70.03; H, 6.64; N, 7.10; O, 16.22

Price and Availability

Size Price Availability Quantity
10mg USD 90.00 Ready to ship
25mg USD 150.00 Ready to ship
50mg USD 250.00 Ready to ship
100mg USD 450.00 Ready to ship
200mg USD 850.00 Ready to ship
500mg USD 1,650.00 Ready to ship
1g USD 2,950.00 Ready to ship
2g USD 4,650.00 Ready to ship
5g USD 6,950.00 2 weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TG4-155; TG-4-155; TG 4-155; TG4155; TG-4155; TG 4155;
IUPAC/Chemical Name
(E)-N-[2-(2-methylindol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide
InChi Key
YBHUXHFZLMFETJ-MDZDMXLPSA-N
InChi Code
InChI=1S/C23H26N2O4/c1-16-13-18-7-5-6-8-19(18)25(16)12-11-24-22(26)10-9-17-14-20(27-2)23(29-4)21(15-17)28-3/h5-10,13-15H,11-12H2,1-4H3,(H,24,26)/b10-9+
SMILES Code
O=C(NCCN1C(C)=CC2=C1C=CC=C2)/C=C/C3=CC(OC)=C(OC)C(OC)=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Solvent mg/mL mM
Solubility
DMF 50.0 126.75
DMSO 68.4 173.30
Ethanol 6.0 15.11
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 394.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Rojas A, Banik A, Chen D, Flood K, Ganesh T, Dingledine R. Novel Microglia Cell Line Expressing the Human EP2 Receptor. ACS Chem Neurosci. 2019 Oct 16;10(10):4280-4292. doi: 10.1021/acschemneuro.9b00311. Epub 2019 Sep 11. PMID: 31469538. 2: Baker SJC, Van Der Kraak G. Investigating the role of prostaglandin receptor isoform EP4b in zebrafish ovulation. Gen Comp Endocrinol. 2019 Nov 1;283:113228. doi: 10.1016/j.ygcen.2019.113228. Epub 2019 Jul 23. PMID: 31348957. 3: Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung DW, Lee JY, Hao J, Jiang J. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype. Sci Rep. 2017 Aug 25;7(1):9459. doi: 10.1038/s41598-017-09528-z. PMID: 28842681; PMCID: PMC5573328. 4: Jiang J, Dingledine R. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. J Pharmacol Exp Ther. 2013 Feb;344(2):360-7. doi: 10.1124/jpet.112.200444. Epub 2012 Nov 28. PMID: 23192657; PMCID: PMC3558819.